Prognostic Factors of Eyes With Naïve Subfoveal Myopic Choroidal Neovascularization After Intravitreal Bevacizumab
Authors:
- Hyun Seung YangHYHyun Seung Yang
- June-Gone KimJKJune-Gone Kim
- Jee Taek KimJKJee Taek Kim
- Soo Geun JoeSJSoo Geun Joe
- 1 December 2013
- journal article
- research article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 156 (6) , 1201-1210.e2
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- OCULAR RISK FACTORS FOR RECURRENCE OF MYOPIC CHOROIDAL NEOVASCULARIZATIONRetina, 2013
- Association between Choroidal Morphology and Anti-Vascular Endothelial Growth Factor Treatment Outcome in Myopic Choroidal NeovascularizationInvestigative Ophthalmology & Visual Science, 2013
- Only first intravitreal bevacizumab injection achieves statistically significant visual improvement in naïve myopic choroidal neovascularizationClinical Ophthalmology, 2012
- Myopic Choroidal NeovascularizationOphthalmology, 2011
- The 12-Month Outcome of Three Consecutive Monthly Intravitreal Injections of Ranibizumab for Myopic Choroidal NeovascularizationJournal of Ocular Pharmacology and Therapeutics, 2011
- PREDICTIVE FACTORS FOR VISUAL OUTCOME TO INTRAVITREAL BEVACIZUMAB IN YOUNG CHINESE PATIENTS WITH MYOPIC CHOROIDAL NEOVASCULARIZATIONRetina, 2011
- Analysis of Choroidal Thickness in Age-Related Macular Degeneration Using Spectral-Domain Optical Coherence TomographyAmerican Journal of Ophthalmology, 2011
- Prognostic factors for visual outcomes 2-years after intravitreal bevacizumab for myopic choroidal neovascularizationEye, 2011
- Multifocal Electroretinogram Findings after Intravitreal Bevacizumab Injection in Choroidal Neovascularization of Age-Related Macular DegenerationKorean Journal of Ophthalmology, 2011
- INTRAVITREAL ANTI-VEGF VERSUS PHOTODYNAMIC THERAPY WITH VERTEPORFIN FOR TREATMENT OF MYOPIC CHOROIDAL NEOVASCULARIZATIONRetina, 2010